Tempus ECG-AF vs Vivid S60N
AI Verdict
Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your primary goal is to proactively identify older patients (65+) at an elevated risk of developing new-onset atrial fibrillation within the next year, using existing 12-lead ECG data. This tool is ideal for risk stratification and guiding earlier follow-up in a population without pre-existing AF.
View Tempus ECG-AF →Choose Vivid S60N if…
Choose GE HealthCare Vivid S60N if you require advanced, real-time cardiovascular ultrasound imaging for immediate diagnosis and and detailed assessment of heart function and anatomy. This system is best suited for comprehensive diagnostic evaluations, including 2D/4D imaging and automated measurements of existing cardiac conditions.
View Vivid S60N →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-AF | Vivid S60N |
|---|---|---|
| Pricing | Contact vendor | Contact vendor for pricing |
| Deployment | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. | On-premise (physical medical device) |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Vivid S60NTool B, the GE HealthCare Vivid S60N, offers a more direct and enhanced user experience through its ergonomic design, intuitive interface, and AI-enabled automation that streamlines sonographer workflows and reduces manual steps. While Tool A integrates into existing ECG workflows, its lack of a dedicated user interface means the user experience is largely dependent on the integrating system.
Clinical Value
Tempus ECG-AFTool A, Tempus ECG-AF, provides a distinct and proactive clinical value by predicting the future risk of atrial fibrillation (AF) within 12 months from a standard ECG, enabling earlier identification and follow-up. This predictive capability, validated in a retrospective study, can potentially prevent AF-related strokes. Tool B, while enhancing existing diagnostic capabilities with AI, focuses on improving current imaging and measurement processes rather than predicting future events.
Pricing & Value
Tempus ECG-AFTool A, Tempus ECG-AF, offers a clearer financial value proposition with established CMS reimbursement codes (CPT 0764T and CPT 0765T) and a specific Medicare rate of $128.90, effective January 1, 2025. This transparency and existing reimbursement pathway make it easier for healthcare facilities to justify and integrate the cost. Tool B, as a physical medical device, has variable pricing and lacks specific reimbursement details in the provided information.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being FDA-cleared and operating within HIPAA-regulated environments. Tool A is a software solution designed for integration with existing EHRs and ECG platforms, while Tool B, a physical device, offers robust DICOM and EMR connectivity with a focus on data security. Both provide comprehensive integration and compliance features essential for healthcare environments.
Innovation
Tempus ECG-AFTool A, Tempus ECG-AF, exhibits greater innovation by applying AI to predict a future medical eventu2014new-onset atrial fibrillation within 12 monthsu2014using a common diagnostic test. This predictive analytics approach represents a significant advancement in proactive risk identification and preventative care. Tool B's AI primarily enhances existing ultrasound imaging and workflow efficiency, which is valuable but less fundamentally innovative in its application of AI.
Support & Docs
Vivid S60NTool B, GE HealthCare Vivid S60N, offers a more comprehensive and explicitly detailed support and documentation ecosystem. This includes physical user and service manuals, 24/7 technical support with dedicated field engineers, ongoing training, automatic software updates, and a dedicated online community with educational resources. While Tool A provides email support and local representatives, Tool B's offerings are more extensive and clearly outlined.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-AF | Vivid S60N |
|---|---|---|
| Name | Tempus ECG-AF | Vivid S60N |
| Company | Tempus AI, Inc. | GE HealthCare |
| Description | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. | Advanced cardiovascular ultrasound systems featuring AI-powered imaging, automated measurements, and workflow enhancements for confident diagnosis and efficient patient care. |
| Key Features | AI-based algorithm for 12-lead ECG analysis; Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months; Intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery; Results interpreted in conjunction with other diagnostic information and clinical history; Compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems; Trained on over 1.5 million ECGs from over 500,000 patients | AI-enabled automation for measurements and workflow; Advanced 2D and 4D ultrasound imaging capabilities; cSoundu2122 software beamformer for exceptional image quality; Advanced quantification tools for heart function and valve anatomy; DICOMu00ae connectivity for seamless integration with reporting systems and EMRs; Ergonomic design with adjustable monitor and control panel; Exceptional mobility and portable design; HDliveu2122 for advanced visualization |
| Specialties | Cardiology, Geriatrics, Internal Medicine | Cardiology, Pediatrics, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-AF and Vivid S60N.